GPC1 and pancreatic neoplasm: A study by Melo et al., used mass spectroscopy identify GPC1 and flow cytometry to isolate GPC1+ exosomes in murine pancreatic cancer models, healthy human subjects, and patients with either benign pancreatic disease as well early to late-stage PDAC.